Home / Featured Companies / Pfizer Historical Data

Pfizer (PFE) Financials

Pfizer (PFE) Historical Financial Statements and Key Metrics for 1990 - 2020

Full Pfizer financials for 1990 - 2020 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Pfizer Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2020-Sep-27 12,131 9,602 (79.2 %) 3,328 (17.9 %) 2,194 (18.1 %) 4,864 0.39
2020-Jun-28 11,801 9,569 (81.1 %) 3,441 (29.2 %) 3,426 (29.0 %) 5,568 0.61
2020-Mar-29 12,028 9,682 (80.5 %) 4,588 (38.1 %) 3,401 (28.3 %) 4,391 0.61
2019-Dec-31 12,688 10,092 (79.5 %) -3,844 (-30.3 %) -336 (-2.6 %) 604 -0.06
2019-Sep-29 12,680 10,225 (80.6 %) 11,113 (87.6 %) 7,680 (60.6 %) 12,688 1.36
2019-Jun-30 13,264 10,714 (80.8 %) 4,430 (33.4 %) 5,046 (38.0 %) 6,048 0.89
2019-Mar-31 13,118 10,707 (81.6 %) 4,625 (35.3 %) 3,884 (29.6 %) 6,223 0.68
Full historical income statements for 1990 - 2020 is included in the US Historical Financials dataset.

Pfizer Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2020-Sep-27 178,983 113,488 61,528 65,259 10,499
2020-Jun-28 177,934 113,598 63,613 64,336 11,382
2020-Mar-29 166,336 101,310 52,288 65,026 10,350
2019-Dec-31 167,489 104,345 52,150 63,144 9,830
2019-Sep-29 170,446 105,343 52,661 65,103 9,087
2019-Jun-30 156,199 96,632 46,675 59,567 12,912
2019-Mar-31 155,421 96,615 45,143 58,806 11,619
Full historical balance sheet data for 1990 - 2020 is included in the US Historical Financials dataset.

Pfizer Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2020-Sep-27 2,090 0 0 1,560
2020-Jun-28 3,556 -13,011 9,159 3,076
2020-Mar-29 3,132 -71 -2,200 2,637
2019-Dec-31 3,769 -2,833 -2,440 3,043
2019-Sep-29 4,508 -6,760 3,273 3,846
2019-Jun-30 2,613 -1,902 -851 2,025
2019-Mar-31 1,697 7,550 -8,467 1,079
Full historical cash flow data for 1990 - 2020 is included in the US Historical Financials dataset.

Pfizer Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2020-Sep-27 191,859 247,348 15.82 87.45 2.94
2020-Jun-28 181,629 241,960 15.39 53.01 2.82
2020-Mar-29 179,810 229,610 14.95 52.87 2.77
2019-Dec-31 212,965 262,348 16.78 -633.82 3.37
2019-Sep-29 195,123 242,568 15.39 25.41 3.00
2019-Jun-30 236,454 279,206 17.83 46.86 3.97
2019-Mar-31 232,550 271,285 17.73 59.87 3.95
Full historical valuation and operating metrics for 1990 - 2020 are included in the US Historical Financials dataset.